Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADPT Adaptive Biotechnologies Corp

交易中 05-12 11:11:27 EDT

9.34

+0.31

+3.43%

最高9.62	最低9.10	成交量30.53万
今开9.49	昨收9.03	日振幅5.70%
总市值14.19亿	流通市值9.32亿	总股本1.52亿
成交额286.79万	换手率0.31%	流通股本9,981万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADPT","market":"US","secType":"STK","nameCN":"Adaptive Biotechnologies Corp","latestPrice":9.34,"timestamp":1747062686581,"preClose":9.03,"halted":0,"volume":305290,"delay":0,"floatShares":99811400,"shares":151916722,"eps":-0.958659,"marketStatus":"交易中","change":0.31,"latestTime":"05-12 11:11:27 EDT","open":9.49,"high":9.615,"low":9.1,"amount":2867886.93304,"amplitude":0.057032,"askPrice":9.35,"askSize":306,"bidPrice":9.33,"bidSize":491,"shortable":3,"etf":0,"ttmEps":-0.958659,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747080000000},"marketStatusCode":2,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":9.03,"preHourTrading":{"tag":"盘前","latestPrice":9.5,"preClose":9.03,"latestTime":"09:29 EDT","volume":25418,"amount":237398.78222000002,"timestamp":1747056599999},"postHourTrading":{"tag":"盘后","latestPrice":9,"preClose":9.03,"latestTime":"19:59 EDT","volume":44182,"amount":398969.82,"timestamp":1746835145105},"volumeRatio":0.331592,"impliedVol":1.4444,"impliedVolPercentile":0.624},"requestUrl":"/m/hq/s/ADPT","defaultTab":"news","newsList":[{"id":"2533654158","title":"Piper Sandler：维持Adaptive Biotechnologies(ADPT.US)评级，由增持调整至增持评级, 目标价由11.00美元调整至13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533654158","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533654158?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:11","pubTimestamp":1746547903,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Adaptive Biotechnologies(ADPT.US)评级，由增持调整至增持评级, 目标价由11.00美元调整至13.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07001150176756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0},{"id":"1118235387","title":"异动解读 | 业绩超预期,Adaptive Biotechnologies盘中大涨32.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118235387","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118235387?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:45","pubTimestamp":1746193518,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp今日盘中股价大涨32.01%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的2025年第一季度财报远超华尔街预期。根据公司公布的财报，截至2025年3月31日的季度中，Adaptive Biotechnologies调整后每股亏损为0.20美元，明显优于分析师平均预期的0.29美元亏损。值得注意的是，尽管当季仍录得2985万美元亏损，但Adaptive Biotechnologies的业绩已连续数个季度超出预期。这一业绩改善和乐观前景推动了公司股价的强劲表现，也反映出投资者对Adaptive Biotechnologies未来发展的信心增强。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2532539844","title":"Adaptive Biotechnologies Corporation盘中异动 快速上涨18.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532539844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532539844?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:31","pubTimestamp":1746192671,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时31分，Adaptive Biotechnologies Corporation股票出现波动，股价大幅拉升18.89%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Polyrizon Ltd.、Impact Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为199.08%、138.47%、52.84%，振幅较大的相关个股有Polyrizon Ltd.、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为8.72%、8.45%、8.04%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213111a6d11c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213111a6d11c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"1184587265","title":"异动解读 | 突破预期！Adaptive Biotechnologies一季度业绩亮眼，盘前大涨11.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184587265","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184587265?lang=zh_cn&edition=full","pubTime":"2025-05-02 20:03","pubTimestamp":1746187436,"startTime":"0","endTime":"0","summary":"周五盘前，Adaptive Biotechnologies Corp股价大涨11.41%，投资者对公司最新发布的第一季度财报反应积极。根据公司公布的财报，截至2025年3月31日的第一季度，Adaptive Biotechnologies调整后每股亏损为0.20美元，明显优于分析师平均预期的0.29美元亏损。分析师对Adaptive Biotechnologies保持乐观态度，目前平均评级为\"买入\"，其中7个为\"强烈买入\"或\"买入\"，1个为\"持有\"，没有\"卖出\"或\"强烈卖出\"评级。值得注意的是，Adaptive Biotechnologies今年以来的股价已上涨22.8%，显示出投资者对公司前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"1105607538","title":"异动解读 | 业绩超预期，Adaptive Biotechnologies盘前大涨11.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105607538","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105607538?lang=zh_cn&edition=full","pubTime":"2025-05-02 20:03","pubTimestamp":1746187431,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp今日盘前股价大涨11.41%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的2025年第一季度财报远超华尔街预期。根据公司公布的财报，截至2025年3月31日的季度中，Adaptive Biotechnologies调整后每股亏损为0.20美元，明显优于分析师平均预期的0.29美元亏损。值得注意的是，尽管当季仍录得2985万美元亏损，但Adaptive Biotechnologies的业绩已连续数个季度超出预期。分析师普遍对公司持积极态度，平均评级为\"买入\"，12个月目标价中位数为10.00美元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 业绩超预期，Adaptive Biotechnologies盘前大涨11.41%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":1},{"id":"2531055939","title":"Adaptive Biotechnologies Corporation盘中异动 早盘股价大跌5.26%报7.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531055939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531055939?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:32","pubTimestamp":1746019925,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时32分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅跳水5.26%。截至发稿，该股报7.21美元/股，成交量1.2412万股，换手率0.01%，振幅2.55%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.27%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213205a6cee80b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213205a6cee80b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2529581450","title":"Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨5.12%报7.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529581450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529581450?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:43","pubTimestamp":1745329438,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时43分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅拉升5.12%。截至发稿，该股报7.18美元/股，成交量20.7844万股，换手率0.14%，振幅3.29%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.23%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214359a6c3dd8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214359a6c3dd8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2526714619","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526714619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526714619?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:43","pubTimestamp":1744393393,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时43分，Adaptive Biotechnologies Corporation股票出现波动，股价急速拉升5.05%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.90%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2117.08%、1654.87%、399.10%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041201431394d31dc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041201431394d31dc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2518322001","title":"Adaptive Biotechnologies Corporation盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518322001?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:08","pubTimestamp":1741615711,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时08分，Adaptive Biotechnologies Corporation股票出现异动，股价快速下挫5.17%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3203.98%、694.50%、99.94%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为40.24%、32.14%、30.40%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220831a26a32b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220831a26a32b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2517102949","title":"Adaptive Biotechnologies Corporation股价重挫14.53% 市值跌1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517102949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517102949?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185062,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Adaptive Biotechnologies Corporation股票出现波动，股价急速下跌14.53%。截至发稿，该股报6.94美元/股，成交量142.435万股，换手率0.96%，振幅0.31%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.08%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103a260c6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2516722206","title":"Adaptive Biotechnologies Corporation盘中异动 大幅下跌5.01%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516722206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516722206?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098754,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Adaptive Biotechnologies Corporation股票出现异动，股价急速下跌5.01%。截至发稿，该股报7.69美元/股，成交量4.0044万股，换手率0.03%，振幅1.81%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.25%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042232349639449a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042232349639449a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2514859250","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速上涨5.11%报8.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859250?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:48","pubTimestamp":1740581323,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时48分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅上涨5.11%。截至发稿，该股报8.85美元/股，成交量9.5112万股，换手率0.06%，振幅4.16%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.28%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224843abddf16d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224843abddf16d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2514016839","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速下挫5.46%报7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016839?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:32","pubTimestamp":1740497541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时32分，Adaptive Biotechnologies Corporation股票出现异动，股价大幅下跌5.46%。截至发稿，该股报7.96美元/股，成交量25.6247万股，换手率0.17%，振幅6.15%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.78%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252332229630008a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252332229630008a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2512387165","title":"Adaptive Biotechnologies Corporation盘中异动 急速拉升5.04%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512387165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512387165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889180,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Adaptive Biotechnologies Corporation股票出现波动，股价急速上涨5.04%。截至发稿，该股报8.75美元/股，成交量4.7002万股，换手率0.03%，振幅3.00%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.11%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223301abd3af7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223301abd3af7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2511670403","title":"Adaptive Biotechnologies Corporation2024财年实现净利润-1.59亿美元，同比增加29.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511670403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511670403?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:00","pubTimestamp":1739635244,"startTime":"0","endTime":"0","summary":"2月16日，Adaptive Biotechnologies Corporation公布财报，公告显示公司2024财年净利润为-1.59亿美元，同比增加29.33%；其中营业收入为1.79亿美元，同比增加5.29%，每股基本收益为-1.08美元。从资产负债表来看，Adaptive Biotechnologies Corporation总负债3.37亿美元，其中短期债务10.24百万美元，资产负债比为1.60，流动比率为0.03。机构评级：截至2025年2月16日，当前有7家机构对Adaptive Biotechnologies Corporation目标价做出预测，其中目标均价为9.00美元，其中最低目标价为7.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000049a24729a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000049a24729a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT"],"gpt_icon":0},{"id":"1155355441","title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155355441","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155355441?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:16","pubTimestamp":1739474195,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Corp(ADPT)股价今日盘中大涨9.93%,引发市场关注。\n\n股价上涨主要受到机构评级目标价上调的利好消息驱动。投行Scotiabank维持对ADPT的评级为\"跑赢大盘\",并将目标价从10美元上调至12美元。此前,ADPT在生物技术行业内表现出较强的发展势头。\n\n作为一家专注于免疫驱动医学的生物科技公司,ADPT的临床诊断产品clonoSEQ已获FDA批准,可用于检测和监测多种血液肿瘤患者的最小残留病情。ADPT正着力将该产品推广至更广泛的淋巴癌适应症。公司在血液肿瘤诊断领域的创新有望为长期增长注入新动能。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Adaptive Biotechnologies Corp盘中大涨9.93%,机构看好前景上调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2511951579","title":"Scotiabank：维持Adaptive Biotechnologies(ADPT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511951579","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511951579?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:11","pubTimestamp":1739473875,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Adaptive Biotechnologies(ADPT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由10.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14031148150865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptivebiotech.com","stockEarnings":[{"period":"1week","weight":-0.0823},{"period":"1month","weight":0.0776},{"period":"3month","weight":0.1518},{"period":"6month","weight":0.5515},{"period":"1year","weight":1.5365},{"period":"ytd","weight":0.5063}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0566},{"period":"1year","weight":0.0849},{"period":"ytd","weight":-0.0371}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。公司正通过利用适应性免疫系统的固有生物学，向疾病的诊断和治疗转变，推进免疫驱动医学领域。该公司认为，适应性免疫系统是大自然对大多数疾病进行的最精细的诊断和治疗，但无法解码使医学界无法充分利用其能力。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司在动态临床免疫组学数据库中捕捉到这些见解，该数据库以计算生物学和机器学习为基础，用于开发和商业化公司正在为每位患者量身定制的临床产品和服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.030966},{"month":2,"riseRate":0.5,"avgChangeRate":-0.017515},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.104089},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.10078},{"month":5,"riseRate":0.5,"avgChangeRate":0.097376},{"month":6,"riseRate":0.8,"avgChangeRate":0.075735},{"month":7,"riseRate":0.5,"avgChangeRate":0.018955},{"month":8,"riseRate":0.5,"avgChangeRate":0.038941},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.099197},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.062214},{"month":11,"riseRate":0.666667,"avgChangeRate":0.035467},{"month":12,"riseRate":0.833333,"avgChangeRate":0.066718}],"exchange":"NASDAQ","name":"Adaptive Biotechnologies Corp","nameEN":"Adaptive Biotechnologies Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptive Biotechnologies Corp,ADPT,Adaptive Biotechnologies Corp股票,Adaptive Biotechnologies Corp股票老虎,Adaptive Biotechnologies Corp股票老虎国际,Adaptive Biotechnologies Corp行情,Adaptive Biotechnologies Corp股票行情,Adaptive Biotechnologies Corp股价,Adaptive Biotechnologies Corp股市,Adaptive Biotechnologies Corp股票价格,Adaptive Biotechnologies Corp股票交易,Adaptive Biotechnologies Corp股票购买,Adaptive Biotechnologies Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}